글로벌 히스톤 데아세틸화효소 억제제 시장 - 2028년까지의 산업 동향 및 예측

히스톤 데아세틸화효소 억제제 시장의 시장 분석 및 통찰력

Data Bridge Market Research는 히스톤 데아세틸화효소 억제제가 2021-2028년 예측 기간 동안 약 15.47%의 CAGR을 보일 것이라고 분석했습니다. 표적 치료 모드에 대한 수요 증가, 신약 및 치료법 개발을 위한 연구 개발 활동 급증, 만성 질환 유병률 증가, 의료 인프라 개발 지출 증가가 히스톤 데아세틸화효소 억제제 시장 성장에 기여하는 주요 요인입니다.

히스톤 데아세틸화효소 억제제는 히스톤 데아세틸화효소를 방해하고 억제하는 새로운 종류의 항암제에 속합니다. 히스톤 데아세틸화효소 억제제는 T세포 림프종과 골수종을 치료하는 데 사용되는 화학 요법제입니다.

규제 당국의 특별 지정 증가와 신경 질환의 유병률 증가는 시장 성장을 촉진하는 주요 요인입니다. 의료 인프라 개발에 대한 지출 증가, 충족되지 않은 치료 요구 증가, 개선되고 효과적인 치료법에 대한 필요성 증가, 전 세계적으로 암 사례 급증, 시장 참여자 간의 전략적 협력 비율 급증은 시장 성장을 촉진하는 다른 요인입니다. 개인의 가처분 소득 증가는 수익성 있는 시장 성장 기회를 창출할 또 다른 간접적인 결정 요인입니다.

그러나 히스톤 탈아세틸화효소 억제제 약물과 관련된 불확실성 문제와 개발도상국과 저개발국 경제권에서의 불리한 상환 시나리오는 시장 성장에 큰 도전이 될 것입니다. 또한 연구 개발 능력과 치료 요법과 관련된 높은 비용은 시장 성장률을 더욱 떨어뜨릴 것입니다.

This histone deacetylase inhibitors market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on histone deacetylase inhibitors market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Histone Deacetylase Inhibitors Market Scope and Market Size

The histone deacetylase inhibitors market is segmented on the basis of classification, application, drugs, route of administration, end users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of classification, the histone deacetylase inhibitors market is segmented into class I HDACs, class II HDACs, class III HDACs and others.
• On the basis of application, the histone deacetylase inhibitors market is segmented into oncology, neurology and others.
• On the basis of drugs, the histone deacetylase inhibitors market is segmented into vorinostat, romidepsin, belinostat and others.  
• On the basis of route of administration, the histone deacetylase inhibitors market is segmented into oral injectable and others.
• On the basis of end users, the histone deacetylase inhibitors market is segmented into hospitals, home care, speciality clinics, and others.
• On the basis of distribution channel, the histone deacetylase inhibitors market is segmented into hospital pharmacy, online pharmacy, retail pharmacy and others.

Histone Deacetylase Inhibitors Market Country Level Analysis

The histone deacetylase inhibitors market is segmented on the basis of classification, application, drugs, route of administration, end users and distribution channel.

The countries covered in the histone deacetylase inhibitors market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the histone deacetylase inhibitors market owing to the earliest adoption of innovative technologies and growing research and development capacities. Asia-Pacific is projected to undergo substantial gains during the forecast period and score the highest CAGR. This is because of the rising expenditure to develop healthcare infrastructure, growing cases of neurological disorders and increasing personal disposable income.

The country section of the histone deacetylase inhibitors market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The histone deacetylase inhibitors market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the histone deacetylase inhibitors market in the growth period.

Competitive Landscape and Histone Deacetylase Inhibitors Market Share Analysis

The histone deacetylase inhibitors market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to histone deacetylase inhibitors market.

히스톤 탈아세틸화효소 억제제 시장 보고서에 포함된 주요 기업으로는 Midatech Pharma PLC, Crystal Genomics Inc., CELGENE CORPORATION, Novartis AG, Shenzhen Chipscreen Biosciences Co., Ltd., Spectrum Pharmaceuticals, Inc., Merck & Co., Inc., Celleron Therapeutics, FORUM Pharmaceuticals Inc., Pfizer Inc., AstraZeneca, Eisai Co., Ltd., REGENACY PHARMACEUTICALS, INC., Karyopharm, Aurobindo Pharma, CARDIFF ONCOLOGY., Wellness Pharma International, Syndax, MEI Pharma, Inc., Onxeo 등이 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 각각 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-50376